Results 81 to 90 of about 23,238 (253)

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

Arthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz, Seza Ozen, Hacer Neslihan Bildik, Canberk Ipsir, Dilara Unal, Saliha Esenboga, Begum Cicek, Mehmet Emin Seker, Fatima Aerts‐Kaya, Seher Sener, Mehmet Orhan Erkan, Hanife Avci, Deniz Cagdas, Ilhan Tezcan   +13 more
wiley   +1 more source

The prevalence of silent myocardial ischaemia in patients with white-coat hypertension [PDF]

, 1998
The aim of this study was to estimate the incidence of silent myocardial ischaemia in patients with mild to moderate hypertension, white-coat hypertension (WCH) and those with normal blood pressure, Ambulatory electrocardiographic (ECG) monitoring was ...
Nalbantgil, S, Boydak, B, Nalbantgil, I, Yilmaz, H, Onder, R   +4 more
core   +1 more source

White Coat Hypertension and Masked Hypertension Among Omani Patients Attending a Tertiary Hospital for Ambulatory Blood Pressure Monitoring

Oman Medical Journal, 2015
Objectives: Our study aimed to estimate the rate of white coat hypertension (WCH) and effect, and masked hypertension in patients attending a tertiary care hospital for 24 hour ambulatory blood pressure monitoring (24-h ABPM).
Khamis Al-Hashmi, Noor Al-Busaidi, Amina BaOmar, Deepali Jaju, Khalid Al-Waili, Khalid Al-Rasadi, Hilal Al-Sabti, Mohammed Al-Abri   +7 more
doaj   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

Atrial Electromechanical Coupling Interval and P-Wave Dispersion in Patients With White Coat Hypertension [PDF]

, 2012
Demir, Vahit/0000-0001-8349-6651Background. The aim of our study was to investigate the effect of white coat hypertension (WCH) to atrial conduction abnormalities by electrocardiographic P-wave analysis and echocardiographic electromechanical coupling ...
Simsek, Fadime, Yildirim, Nesligul, Tulmac, Murat, Dogru, Mehmet Tolga, Simsek, Vedat, Ebinc, Haksun, Alp, Caglar   +6 more
core   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

White coat hypertension in early pregnancy in women with pre-existing diabetes:prevalence and pregnancy outcomes [PDF]

, 2019
Aims/hypothesis: Hypertensive disorders are prevalent among pregnant women with pre-existing diabetes, but the prevalence and impact of white coat hypertension are unknown.
Vestgaard, Marianne, Andersen, Lise Lotte T, Jensen, Dorte M; id_orcid, Damm, Peter, Mathiesen, Elisabeth R., Mathiesen, Elisabeth R, Ringholm, Lene, Andersen, Lise Lotte T., Ásbjörnsdóttir, Björg, Jensen, Dorte M.   +9 more
core   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Association between white-coat effect and blunted dipping of nocturnal blood pressure. [PDF]

, 2009
In this study, we assessed whether the white-coat effect (difference between office and daytime blood pressure (BP)) is associated with nondipping (absence of BP decrease at night).
Bochud, M., Vollenweider, P., Wandeler, G., Burnier, M., Paccaud, F., Bovet, P., Maillard, M., Gabriel, A.   +7 more
core   +1 more source

The use of automated sequential blood pressure in hypertension clinics compared with office and ambulatory blood pressure measurements

The Egyptian Heart Journal, 2020
Background Office blood pressure (OBP) measurement is the most common method of blood pressure measurement. However, it is associated with several pitfalls as white coat effect and masked hypertension.
Kareem Mahmoud, Ayah ElAroussy, Yasser Baghdady, Wafaa ElAroussy, Heba ElDeeb   +4 more
doaj   +1 more source